CAS: 40635-11-8; 6,7-Dichloroquinoline
该化合物是一种卤化的奎宁衍生物,配有分子式C9H5Cl2N. 这种环形化合物的特点是,在奎诺林环的6和7个位置上存在氯原子,这增强了其在有机合成中的回作用和效用;它是制药,农用化学品和特殊化学品的制作的多用途中间体;二氯替代模式具有不同的电子特性,对建造复杂的分子结构很有价值;其稳定性和与各种反应条件的兼容性进一步有助于其在研究和工业应用中广泛使用氯原子;建议适当处理和储存,因为其具有潜在的回性.
- 相似结构搜索
- 产品信息参考
- InChIKey: VOEBOQZMOGFLTJ-UHFFFAOYSA-N
- InChI=1S/C9H5Cl2N/c10-7-4-6-2-1-3-12-9(6)5-8(7)11/h1-5H
- 计算化学: 氢键受体数1.0氢键供体数*可旋转键数*
相似化合物
612-61-3 612-57-7 4203-18-3物理性质
MSDS等安全信息
上下游产品
CAS号56-81-5 甘油 | CAS号95-76-1 3,4-二氯苯胺 | CAS号333383-84-9 N-(3,4-dichloro... | CAS号17847-44-8 N-Methansulfony...合成工艺路线路线简述
📜甲磺酰胺,N-(3,4-二氯苯基)-置于三氟甲磺酸,三乙胺体系中,用 甲醇,二氯甲烷 作为反应溶剂,化学反应 0.17H,反应生成 6,7-二氯喹啉
参考文献:Tokuyama,Hidetoshi; Sato,Masashi; Ueda,Toshihiro,Heterocycles,2001,Vol. 54,# 1,P. 105-108
标题:Tokuyama,Hidetoshi; Sato,Masashi; Ueda,Toshihiro,Heterocycles,2001,Vol. 54,# 1,P. 105-108
海关参考信息
- 2933310010-吡啶
2903911000-邻二氯苯
2939800000-其他生物碱 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-7897774-B2
优先权日:2005-03-03
标题:Cyclic compound having quinolylalkylthio group
发明人：KAWASHIMA KENJI; HONDA TAKAHIRO; TAJIMA HISASHI; OKAMOTO KAZUYOSHI; YAMAMOTO MINORU
权利人:SANTEN PHARMACEUTICAL CO LTD
摘要:The present invention relates to a synthesis study of novel cyclic compounds having a quinolylalkylthio group represented by the formula (1), and pharmacological actions of the compounds. n nIn the formula, the ring X represents:n n nwhich may have halogen and/or alkyl; R 1 and R 2 independently represent hydrogen, alkyl, cycloalkyl, aryl or a (non) aromatic heterocycle; R 3 represents qinolyl; A represents sulfur, sulfinyl or sulfonyl; and B represents alkylene.
专利号:EP-1465880-B1
优先权日:2001-11-28
标题 :5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine
发明人：GALCERA CONTOUR MARIE-ODILE; SIDHU ALBAN; ROUBERT PIERRE; THURIEAU CHRISTOPHE
权利人:IPSEN PHARMA
摘要:The invention concerns novel 5-sulphanyl-4H-1,2,4-triazole derivatives of formula (I), wherein: R1, R2 and R3 represent variable groups and the methods for preparing them by liquid-phase parallel synthesis processes. Said product exhibit good affinity for certain sub-types of somatostatin receptors; they are particularly useful for treating pathological conditions or diseases wherein one (or more) somatostatin receptors is (are) involved. The invention also concerns pharmaceutical compositions containing said products and their use for preparing a medicine.
